Patents
Sitemap › C07 - Organic chemistry › C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium › C07F 9 - Compounds containing elements of the 5th group of the periodic system
Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
07/2010
07/08/2010WO2010076258A1 Phenylalkyl-imidazole-bisphosphonate compounds
07/08/2010WO2010056527A3 B-biphenyl sulfonamide compounds as ion channel modulators
07/08/2010US20100174110 Process for the manufacture of alkylamino alkylene phosphonic acids
07/08/2010US20100174079 Process for production of optically active phosphorous compound
07/08/2010US20100174058 Fluorescent quenching detecting reagents and methods
07/08/2010US20100174007 Haloneopentyl Bis(ALKYL) Phosphate Ester, Flame Retardant Composition Containing Same and Polyurethane Foam Prepared Therewith
07/08/2010US20100173870 Phosphonate Compounds
07/08/2010US20100173863 2-Fluoronucleosides
07/08/2010US20100173195 Material for electrolytic solutions and use thereof
07/08/2010US20100173166 Fluorinated compositions and surface treatments made therefrom
07/08/2010US20100172967 Compound modified with glycerol derivative
07/08/2010US20100170418 Complexes of carbon nanotubes and fullerenes with molecular-clips and use thereof
07/08/2010CA2748607A1 Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
07/08/2010CA2748313A1 Novel fluorescent boron-substituted dipyrromethenes and use thereof for diagnosis
07/08/2010CA2746612A1 Phenylalkyl-imidazole-bisphosphonate compounds
07/07/2010EP2204374A1 Nucleoside phosphonates and analogs thereof for the treatment of HPV-infections
07/07/2010EP2204373A1 Phosphonic acid as Plasma Carboxypeptidase B Inhibitors
07/07/2010EP2204372A1 Process for the preparation of thiophosphoric acid triamides with non-polar amines
07/07/2010EP1597244B1 Ethynyl derivatives serving as factor xa inhibitors
07/07/2010CN101768190A Improvement method for refining and extracting technique in production process of fosphenytoin sodium intermediate
07/07/2010CN101768189A O,O-methylethyl-O-3,5,6-trichloro-2-pyridyl phosphonothioic acid ester organophosphorus pesticidal and acaricidal agent
07/07/2010CN101768188A Synthetic method of maleimide phosphatidyl ethanolamine
07/07/2010CN101768187A Application of hydroxymethyl sodium glycinate and hydroxymethyl glycine hydrochloride in preparation of glyphosate
07/07/2010CN101768186A Chlorine glyphosate and oxidized glyphosate and preparation and purposes thereof
07/07/2010CN101768185A Dipropofol dihydrogen pyrophosphate and salt thereof, preparation method and application thereof
07/06/2010US7750180 Reaction of an excess of amine substrate with a halomethylphosphonic acid or salt, a hydroxymethylphosphonic acid or salt or a dehydrated self-ester dimer, trimer or oligomer of hydroxymethylphosphonic acid to produce glyphosate and N-phosphonomethylaminoalkanols; by-product inhibition
07/06/2010US7750173 Tantalum amido-complexes with chelate ligands useful for CVD and ALD of TaN and Ta205 thin films
07/06/2010US7750172 Stable in the presence of a variety of functional groups and can be used to catalyze olefin metathesis reactions on unstrained cyclic and acyclic olefins; high initiation rates; easily prepared
07/06/2010US7750171 Mixture of metal catalyst and organophosphorous inhibitor; mixing into solution of unsaturated silane or siloxane
07/06/2010US7750021 3-{[2-(2-Trifluoromethyl-biphenyl-4-yl)-benzo[b]thiophen-5-ylmethyl]-amino}-propionic acid, useful in the treatment or prevention diseases associated with endothelial differentiation, G-protein-coupled (EDG) receptor mediated signal transduction, such as acute or chronic transplant rejection
07/06/2010US7750008 poly(ADP-ribose) polymerase (PARP) inhibitors such as 9-[(Hydrozinooxy)carbonyl]-2,7-dihydro-6-methoxy 3H-pyrido-[4,3,2-de]phthalazin-3-one, used for treating neuron tissue damage resulting from ischemia and reperfusion injury, depression, inflammatory bowel disorders, arthritis, gout, pain and sepsis
07/06/2010US7749985 3-{[1-Isobutanoyloxyethoxy]carbonylamino}propyl(n-butyl)phosphinic acid, used treating a disease chosen from mild cognitive impairment, cognitive impairment associated with Alzheimer's disease, depression, anxiety and epilepsy; intermediates for 3-aminopropylphosphinic acid and analogs
07/06/2010US7749760 Nutrient broth comprising zoledronate, interleukin 2, and interleukin 18 for use in propagation of tumor specific lymphocytes; antitumor agents; tissue targeted therapy; immunotherapy
07/06/2010CA2391425C Transition metal complexes with bidentate ligand having an imidazole ring
07/06/2010CA2248242C Malononitrile-derivative anion salts, and their uses as ionic conducting materials
07/01/2010WO2010075276A1 Water miscible solvent based process for purifying a bisphosphate
07/01/2010WO2010074384A1 Novel phosphonate compounds and flame retardant styrene resin compositions containing the same
07/01/2010WO2010074277A1 Process for production of purified o-(2,6-dichloro-4-methyl- phenyl) o,o-dimethyl phosphorothioate
07/01/2010WO2010072746A1 Chiral ligands
07/01/2010WO2010072184A2 Liquid composition containing phosphoric or thiophosphoric triamide derivative and use thereof
07/01/2010WO2010072002A1 Metal hydrazide materials
07/01/2010WO2010051890A3 Method for producing mono-vinylfunctionalized dialkylphosphinic acid, salts and esters thereof, and the use thereof
07/01/2010WO2010051887A8 Method for producing dialkylphosphinic acids and esters and salts thereof by means of vinyl compounds and use thereof
07/01/2010US20100168456 Chiral phosphorous compounds
07/01/2010US20100168422 Methods and intermediates useful in the synthesis of hexahydrofuro [2,3-b]furan-3-ol
07/01/2010US20100168403 Protein refolding agent and refolding method
07/01/2010US20100168379 Epichlorohydrin, manufacturing process and use
07/01/2010US20100168359 Tri-functional uv-absorbing compounds and use thereof
07/01/2010US20100168068 Mao-b inhibitors useful for treating obesity
07/01/2010US20100168066 Novel insecticides
07/01/2010US20100168065 Quinolinone derivatives as parp and tank inhibitors
07/01/2010US20100168064 Novel hydrophilic derivatives of 2-aryl-4-quinolones as anticancer agents
07/01/2010US20100168063 Bicyclic pyrimidinones and uses thereof
07/01/2010US20100166838 Methods And Compositions For Modulating Keratinocyte Function
07/01/2010US20100166662 Magnetic resonance imaging method using vanadyl-based contrast agents
07/01/2010US20100166624 Methods for selectively separating carbon nanotubes
07/01/2010DE19741777B4 Monomere Bisphosphite als Stabilisatoren für halogenhaltige Polymere und für Schmierstoffe Bisphosphites monomers as stabilizers for halogen-containing polymers and lubricants
07/01/2010DE102009041787A1 Organische Verbindungen zur dualen Oberflächenfunktionalisierung und deren Verwendung Organic compounds for the dual surface functionalization and their use
07/01/2010DE102008063668A1 Verfahren zur Herstellung von Alkylphosponsäuren, -estern und -salzen mittels Oxidation von Alkylphosphonigsäuren und ihre Verwendung A process for preparing Alkylphosponsäuren, esters and salts by means of oxidation of alkylphosphonous acids and their use
07/01/2010CA2747994A1 Chiral ligands
07/01/2010CA2747821A1 Metal hydrazide materials
07/01/2010CA2745584A1 Liquid composition containing phosphoric or thiophosphoric triamide derivative and use thereof
06/2010
06/30/2010EP2202238A1 Nucleotide Compounds including a rigid linker
06/30/2010EP2202236A1 Chiral ligands
06/30/2010EP2201025A1 Functional lipid constructs
06/30/2010EP1495035B1 Method for the production of bis(perfluoroalkyl)phosphinic acids and the salts thereof
06/30/2010EP1425245B1 Method for preparing stable dispersions of metallic nanoparticles, stable dispersions obtained therefrom and coating compositions containing them
06/30/2010EP1278737B1 Process and intermediates for making substituted aspartic acid acetals
06/30/2010CN101759722A Novel acyclic nucleoside phosphonate predrug
06/30/2010CN101759721A Preparation method for low-cost high-purity fosfomycin sodium
06/30/2010CN101759720A Acyclic nucleoside phosphonate compounds or pharmaceutically acceptable salts thereof, preparation method, application, intermediate compounds thereof, and medicinal composition containing same
06/30/2010CN101759719A Method for synthesizing fosfomycin phenylethylamine calt
06/30/2010CN101759718A Method for producing N-(Phosphonomethyl)iminodiacetic acid
06/30/2010CN101759717A Method for synthesizing N-(n-butyl)thiophosphoric triamide
06/30/2010CN101759716A Preparation method for water-soluble pleuromutilin compound and intermediate thereof
06/30/2010CN101755831A Production method of glyphosate solution
06/29/2010US7745666 Method for producing aldehyde using bisphosphite and group 8-10 metal compound, and such bisphosphite
06/29/2010US7745660 Process for recovering a crystalline product from solution
06/29/2010US7745655 Reacting salisylic acid with phosphorus trichloride in toluene in presence of triethylamine base to form an intermediate, reacting intermediate wtih a phosphite compound to form bisphosphites
06/29/2010US7745627 Method for the production of heteroleptic ortho-metallated organometallic compounds
06/29/2010US7745625 Phosphate prodrugs; treating HIV infection; 1-(phosphomethyl)-3-(2-(4-benzoylpiperazin-1-yl)-1,2-dioxoethyl)-4,7-dimethoxy-1H-pyrrolo(2,3-c)pyridine for example; improved water solubility, bioavailability for oral administration
06/29/2010US7745614 genetic probes modified at the 5' terminus by a functional group, which is linked to the nucleic acid through an activating leaving group and a tether, that provide for detectable or functional changes following their release from the modified nucleic acid; kits for detecting of nucleic acid sequences
06/29/2010US7745489 Potent 2-oxo-amide based compounds; abrogating prostaglandin production; low dosage; spinal cord and central nervous system pain
06/29/2010US7745422 Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases
06/29/2010US7744838 Functionalized ionic liquids, and methods of use thereof
06/29/2010CA2426885C Complexes of phosphate derivatives
06/29/2010CA2195169C Transfection competent molecules
06/24/2010WO2010071097A1 Method for producing lithium difluorobis(oxalato)phosphate solution
06/24/2010WO2010069545A2 Process for preparing ethylenedialkylphosphinic acids, esters and salts by means of acetylene and use thereof
06/24/2010WO2010069421A1 Hydrophosphorylation of phosphonous acid derivatives for flame retardants
06/24/2010WO2010069420A1 Method for the production of monofunctionalized dialkylphosphinic acids, esters, and salts, and use thereof
06/24/2010WO2010069419A1 Method for the production of mixed-substituted dialkylphosphinic acids, esters, and salts, and use thereof
06/24/2010WO2010069418A1 Method for the production of alkylphosphonic acids, esters, and salts by oxidizing alkylphosphonous acids, and use thereof
06/24/2010WO2010069417A1 Method for the production of monohydroxy-functionalized dialkylphosphinic acids, esters, and salts using ethylene oxide, and use thereof
06/24/2010WO2010069416A1 Process for preparing mono-carboxy-functionalized dialkylphosphinic acids, esters and salts by means of alkylene oxides and use thereof
06/24/2010WO2010042887A3 Methods for preparing oxazolidinones and compositions containing them
06/24/2010WO2010019511A3 Phosphonated rifamycins and uses thereof for the prevention and treatment of bone and joint infections
06/24/2010WO2010001085A3 Process for the recovery of a phosphonic acid and concersion of a phosphonic acid to a phosphonic acid anhydride
06/24/2010US20100160681 Chiral phosphoramides, chiral N-phosphonimines and methods for forming the same
06/24/2010US20100160645 Poly(ethylene glycol) containing chemically disparate endgroups
1 ... 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 ... 554